The technology used in the Samsung SBM-100A, to measure blood pressure, has failed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||Not recommended||This device failed clinical validation.|
Altunkan S, Ilman N, Altunkan E. Validation of the Samsung SBM-100A and Microlife BP 3BU1-5 wrist blood pressure measuring devices in adults according to the International Protocol. Blood Press Monit. 2007 Apr;12(2):119-25. PMID: 17353656.
ESH-IP:2002 - Fail General population